<DOC>
	<DOC>NCT02092402</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of fecal microbiota transplantation (FMT) on the symptoms of irritable bowel syndrome (IBS) patients.</brief_summary>
	<brief_title>Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Inclusion criteria for patients 1. Signed informed consent 2. Fulfilled Rome III diagnostic criteria for IBS, and frequency of IBS pain or discomfort for at least 2 days a week in the last 12 weeks 3. Age: 1865 years Exclusion criteria for patients 1. High proportion of butyrateproducing microbiota in fecal samples 2. Known organic gastrointestinal disease (e.g. IBD) 3. Previous complicated gastrointestinal surgery 4. Nongastrointestinal malignancy 5. Dementia, severe depression, major psychiatric disorder, or other incapacity for adequate cooperation 6. Females who are pregnant or breastfeeding 7. Severe endometriosis 8. Antimicrobial treatment 4 weeks prior to first screening visit 9. Antimicrobial prophylaxis (eg. acne, urinary tract infection) 10. Regular consumption of probiotic products 4 weeks prior to randomization 11. Recently (within the last 3 months) diagnosed lactose intolerance 12. Celiac disease 13. Abuse of alcohol or drugs 14. Any clinically significant disease/condition which in the investigator's opinion could interfere with the results of the trial Inclusion criteria for donors 1. Signed informed consent 2. Highbutyrate producing microbiota in fecal samples 3. Age: 1865 years Exclusion criteria for donors 1. Known organic gastrointestinal disease (e.g. IBD, IBS, chronic diarrhea or constipation) 2. Gastrointestinal malignancy or polyposis 3. History of major gastrointestinal surgery (e.g. gastric bypass) 4. Eosinophilic disorders of the gastrointestinal tract 5. Current communicable disease (e.g. upper respiratory tract infection) 6. Known or high risk of infectious diseases such as HIV, hepatitis A, B or C 7. Nongastrointestinal malignancy 8. Dementia, severe depression, major psychiatric disorder, or other incapacity for adequate cooperation 9. Comorbidities such as metabolic syndrome, autoimmune diseases, allergies 10. Chronic pain syndromes (eg. chronic fatigue syndrome, fibromyalgia) 11. Severe or morbid obesity 12. Use of immunosuppressive or chemotherapy agents 13. Antimicrobial treatment or prophylaxis within the last 6 months 14. Females who are pregnant or breastfeeding 15. Known clinically significant abnormal laboratory values 16. Participation in highrisk sexual behaviors 17. Abuse of alcohol or drugs 18. Tattoo or body piercing within the last 6 months 19. Travel to areas with endemic diarrhea during the last 3 months 20. Positive stool testing for C. difficile toxin, ova, parasites, Giarda antigen, cryptosporidium antigen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Fecal transplantation</keyword>
	<keyword>microbiota transplantation</keyword>
	<keyword>irritable bowel syndrome</keyword>
	<keyword>IBS</keyword>
</DOC>